Price

rebased to 0%

PFE, solidJNJ, dashed

PFEPfizer Inc

29.98−2.25%· post 30.10

Mkt cap$174.8BRevenue$16.6BQ3 FY26Revenue$62.6BFY25

JNJJohnson & Johnson

266.16−1.63%· post 266.20

ClosedNov 3 '26

Mkt cap$651.3BRevenue$25.4BQ3 FY26Revenue$94.2BFY25

vs

Compare

ClosedNov 3 '26

PFEPfizer Inc

vs

JNJJohnson & Johnson

29.98−2.25%post 30.10

Price

266.16−1.63%post 266.20

$174.8B

Mkt cap

$651.3B

Q3 FY26$16.6B

Revenue

$25.4BQ3 FY26

FY25$62.6B

Revenue

$94.2BFY25

PFE compared with JNJ: revenue, margins and what each company keeps, and the suppliers and customers both name